Clinical trial
Role of Trem-1 in Ultraviolet Radiation-induced Immune Suppression
NCT05020496 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Trem-1 in Ultraviolet Radiation-induced Immune Suppression
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- March 21, 2022
- Completion date
- October 1, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.